Overview

Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-20
Target enrollment:
Participant gender:
Summary
The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury
Phase:
PHASE3
Details
Lead Sponsor:
Tanta University
Treatments:
Control Groups
Propranolol